KIDNEY TRANSPLANT; COMPLICATIONS
Clinical trials for KIDNEY TRANSPLANT; COMPLICATIONS explained in plain language.
Never miss a new study
Get alerted when new KIDNEY TRANSPLANT; COMPLICATIONS trials appear
Sign up with your email to follow new studies for KIDNEY TRANSPLANT; COMPLICATIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Home workouts may boost heart health after kidney transplant
Disease control OngoingThis study tests whether a 12-week, home-based exercise program can improve heart health in people who have had a kidney transplant. Heart problems are the leading cause of death in these patients, partly due to common conditions like high blood pressure and diabetes, plus the me…
Matched conditions: KIDNEY TRANSPLANT; COMPLICATIONS
Phase: NA • Sponsor: University of Leicester • Aim: Disease control
Last updated May 17, 2026 02:45 UTC
-
Plant-Based diet trial aims to cut kidney transplant complications
Disease control OngoingThis study tests whether teaching kidney transplant recipients to eat a whole-food plant-based diet can improve their blood pressure, blood sugar, and weight, and reduce hospital visits. About 49 adults who had a kidney transplant in the past year and have high blood pressure, hi…
Matched conditions: KIDNEY TRANSPLANT; COMPLICATIONS
Phase: NA • Sponsor: University of California, Davis • Aim: Disease control
Last updated May 17, 2026 02:43 UTC
-
Robots vs scalpels: can robotic surgery make kidney transplants safer?
Disease control OngoingThis study tests if robot-assisted kidney transplant surgery causes fewer serious problems (like bleeding or blood clots) within 30 days compared to standard open surgery. About 106 adults with kidney failure who need a transplant will be randomly assigned to one of the two metho…
Matched conditions: KIDNEY TRANSPLANT; COMPLICATIONS
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Disease control
Last updated May 17, 2026 02:42 UTC
-
New hope for kidney transplant patients: a better way to prevent a dangerous virus?
Disease control OngoingThis study tests whether a newer drug, letermovir, works better than the standard valganciclovir to prevent CMV (a common virus) in African American kidney transplant recipients. About 30 high-risk patients will take letermovir for 6 months after transplant, and their results wil…
Matched conditions: KIDNEY TRANSPLANT; COMPLICATIONS
Phase: PHASE3 • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated May 17, 2026 02:40 UTC
-
Kidney transplant virus study pulled before it began
Disease control TerminatedThis study aimed to see if a special blood filter (Seraph 100) could reduce BK virus levels in kidney transplant patients with high viral loads. It planned to enroll adults with BK virus levels of 10,000 IU/mL or more who already had dialysis access. However, the study was withdr…
Matched conditions: KIDNEY TRANSPLANT; COMPLICATIONS
Phase: NA • Sponsor: ExThera Medical Europe BV • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
Could a bone marrow transplant free kidney patients from lifelong drugs?
Disease control OngoingThis study tests whether a bone marrow transplant given after a kidney transplant can help the body accept the new kidney without needing lifelong anti-rejection drugs. About 20 adults aged 18-65 who already have a well-functioning kidney transplant will receive an experimental t…
Matched conditions: KIDNEY TRANSPLANT; COMPLICATIONS
Phase: PHASE1, PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
Which tacrolimus is better for black kidney transplant patients?
Disease control OngoingThis study looks at two versions of a drug called tacrolimus, which helps prevent the body from rejecting a new kidney. It focuses on African American kidney transplant recipients to see if taking the drug once a day (extended release) is better for blood vessel health than takin…
Matched conditions: KIDNEY TRANSPLANT; COMPLICATIONS
Phase: PHASE4 • Sponsor: Roy D. Bloom, MD • Aim: Disease control
Last updated May 11, 2026 20:37 UTC
-
Breakthrough drug combo may stop hepatitis c spread in organ transplants
Prevention OngoingThis study tests whether a short course of two drugs (glecaprevir/pibrentasvir and ezetimibe) can prevent hepatitis C infection in people who receive a kidney, heart, lung, or pancreas from a hepatitis C-positive donor. About 200 participants who are hepatitis C-negative and awai…
Matched conditions: KIDNEY TRANSPLANT; COMPLICATIONS
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Prevention
Last updated May 11, 2026 20:38 UTC
-
Immune cell test may predict kidney transplant success
Knowledge-focused OngoingThis study is testing whether measuring a specific type of immune cell (regulatory T cells) before a kidney transplant can predict if the new kidney will start working slowly or with delay. Researchers will follow 180 adult kidney transplant patients to see if these cells can ser…
Matched conditions: KIDNEY TRANSPLANT; COMPLICATIONS
Sponsor: St. Louis University • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC
-
Kidney transplant study pulled before it even started
Knowledge-focused TerminatedThis study aimed to see if sodium bicarbonate (Nephrotrans®) could reduce the risk of harmful calcium buildup in the blood of kidney transplant recipients. It planned to enroll adults who had a kidney transplant at least six months earlier. However, the study was withdrawn before…
Matched conditions: KIDNEY TRANSPLANT; COMPLICATIONS
Phase: PHASE2 • Sponsor: Prim. Priv. Doz. Dr. Daniel Cejka • Aim: Knowledge-focused
Last updated May 06, 2026 16:14 UTC